BioTime to Participate at the BIO CEO and Investor Conference in New York, February 12th and 13th 2018
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a late-stage, clinical biotechnology company developing and commercializing products addressing degenerative diseases, today announced that Adi Mohanty, Co-Chief Executive Officer of BioTime, will participate in the BIO CEO and Investor Conference, on February 12th and 13th 2018, at the New York Marriott Marquis. The BIO CEO and Investor Conference is one of the largest investor conferences focused on established and emerging